Citation

87 FR 2616

Multiple canonical documents share this first-page citation.

Fresenius USA, Inc., et al.; Withdrawal of Approval of 216 Abbreviated New Drug Applications; Correction Tuesday, January 18, 2022 87 FR 2616
Determination That PEPCID (Famotidine) Tablet, 20 Milligrams and 40 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness Tuesday, January 18, 2022 87 FR 2616